Tech Company Financing Transactions
ReGen Biologics Funding Round
F-Prime Capital invested in a $7.9 million venture round for ReGen Biologics. The round closed on 12/31/2013.
Transaction Overview
Company Name
Announced On
12/31/2013
Transaction Type
Venture Equity
Amount
$7,892,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
411 Hackensack Avenue
Hackensack, NJ 07601
USA
Hackensack, NJ 07601
USA
Phone
Website
Email Address
Overview
Develops implantable regeneration templates for knee meniscal cartilage.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gerald Bisbee
Chief Financial Officer
Brion Umidi
VP - Regulatory Affairs
John Dichiara
Browse more venture capital transactions:
Prev: 12/31/2013: Lunar Software venture capital transaction
Next: 12/31/2013: Ethical Electric venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs